Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines
- 25 September 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (42), 5885-5895
- https://doi.org/10.1016/j.vaccine.2009.07.039
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challengeNature Medicine, 2009
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisThe Lancet, 2008
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialThe Lancet, 2008
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeysNature, 2008
- Challenges in the development of an HIV-1 vaccineNature, 2008
- Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipientsThe Journal of Experimental Medicine, 2008
- Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccinesVaccine, 2008
- Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primateVirology, 2007
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006
- Poxvirus CD8+T-Cell Determinants and Cross-Reactivity in BALB/c MiceJournal of Virology, 2006